Justin A. Ezekowitz

Research interests

Publications

• Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

  New England Journal of Medicine · 2024 · https://doi.org/10.1056/nejmoa2313917

• Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

  The Lancet · 2024 · 10.1016/s0140-6736(24)00469-0

• Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2306963

• Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions

  Journal of the American College of Cardiology · 2023 · 10.1016/j.jacc.2022.11.023

• 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab368

• CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction

  Canadian Journal of Cardiology · 2021 · 10.1016/j.cjca.2021.01.017

• Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries

  Circulation · 2021 · 10.1161/circulationaha.120.050850

• Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction

  JAMA · 2020 · 10.1001/jama.2020.15922

• Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

  New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1915928

• Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

  Journal of Clinical Oncology · 2017 · 10.1200/jco.2016.68.7830

• 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure

  Canadian Journal of Cardiology · 2017 · 10.1016/j.cjca.2017.08.022

• Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

  JAMA · 2017 · 10.1001/jama.2017.10565

• Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

  The Lancet · 2016 · 10.1016/s0140-6736(16)32049-9

• Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function

  JACC. Cardiovascular imaging · 2015 · 10.1016/j.jcmg.2015.02.014

• Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function

  JACC. Cardiovascular imaging · 2015 · 10.1016/j.jcmg.2015.02.014

• The Effects of Climate Change on Cardiac Health

  Cardiology · 2015 · https://doi.org/10.1159/000398787

• Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

  New England Journal of Medicine · 2011 · 10.1056/nejmoa1100171

• Apixaban versus Warfarin in Patients with Atrial Fibrillation

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1107039

• Declining In-Hospital Mortality and Increasing Heart Failure Incidence in Elderly Patients With First Myocardial Infarction

  Journal of the American College of Cardiology · 2008 · 10.1016/j.jacc.2008.08.067

• Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction

  JAMA · 2007 · 10.1001/jama.297.22.2502

• The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

  Journal of the American College of Cardiology · 2004 · 10.1016/j.jacc.2004.06.072

• Renal Insufficiency and Heart Failure

  Circulation · 2004 · 10.1161/01.cir.0000116764.53225.a9

• Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure

  Annals of Internal Medicine · 2004 · 10.7326/0003-4819-141-5-200409070-00101

• Implantable Cardioverter Defibrillators in Primary and Secondary Prevention

  Annals of Internal Medicine · 2003 · 10.7326/0003-4819-138-6-200303180-00007

• Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

  Circulation · 2003 · 10.1161/01.cir.0000052622.51963.fc

Current projects

No projects listed.